These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15109656

  • 1. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
    Kato Y, Nakano Y, Sano H, Tanatani A, Kobayashi H, Shimazawa R, Koshino H, Hashimoto Y, Nagasawa K.
    Bioorg Med Chem Lett; 2004 May 17; 14(10):2579-83. PubMed ID: 15109656
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structure-activity relationship studies on vitamin D lactam derivatives as vitamin D receptor antagonist.
    Cho K, Uneuchi F, Kato-Nakamura Y, Namekawa J, Ishizuka S, Takenouchi K, Nagasawa K.
    Bioorg Med Chem Lett; 2008 Aug 01; 18(15):4287-90. PubMed ID: 18635349
    [Abstract] [Full Text] [Related]

  • 4. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts.
    Inada M, Tsukamoto K, Hirata M, Takita M, Nagasawa K, Miyaura C.
    Biochem Biophys Res Commun; 2008 Aug 01; 372(3):434-9. PubMed ID: 18489902
    [Abstract] [Full Text] [Related]

  • 5. 1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
    Ishizuka S, Kurihara N, Hiruma Y, Miura D, Namekawa J, Tamura A, Kato-Nakamura Y, Nakano Y, Takenouchi K, Hashimoto Y, Nagasawa K, Roodman GD.
    J Steroid Biochem Mol Biol; 2008 Jun 01; 110(3-5):269-77. PubMed ID: 18501591
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthetic studies of (23S,25R)-1α,25-dihydroxyvitamin D3 26,23-lactone (calcitriol lactone) and its derivatives.
    Akagi Y, Nagata A, Odagi M, Nagasawa K.
    J Steroid Biochem Mol Biol; 2018 Mar 01; 177():240-246. PubMed ID: 28757443
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes.
    Takaku H, Miyamoto Y, Asami S, Shimazaki M, Yamada S, Yamamoto K, Udagawa N, DeLuca HF, Shimizu M.
    Bioorg Med Chem; 2008 Feb 15; 16(4):1796-815. PubMed ID: 18032055
    [Abstract] [Full Text] [Related]

  • 10. Effect of 25-hydroxyl group orientation on biological activity and binding to the 1alpha,25-dihydroxy vitamin D3 receptor.
    Collins ED, Bishop JE, Bula CM, Acevedo A, Okamura WH, Norman AW.
    J Steroid Biochem Mol Biol; 2005 Mar 15; 94(4):279-88. PubMed ID: 15857747
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs.
    Takayama H, Kittaka A, Fujishima T, Suhara Y.
    Recent Results Cancer Res; 2003 Mar 15; 164():289-317. PubMed ID: 12899530
    [Abstract] [Full Text] [Related]

  • 12. Novel 1alpha,25-dihydroxyvitamin D3 analogues with the side chain at C12.
    González-Avión XC, Mouriño A, Rochel N, Moras D.
    J Med Chem; 2006 Mar 09; 49(5):1509-16. PubMed ID: 16509569
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
    Shimizu M, Miyamoto Y, Kobayashi E, Shimazaki M, Yamamoto K, Reischl W, Yamada S.
    Bioorg Med Chem; 2006 Jun 15; 14(12):4277-94. PubMed ID: 16503143
    [Abstract] [Full Text] [Related]

  • 14. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
    Arai MA, Kittaka A.
    Anticancer Res; 2006 Jun 15; 26(4A):2621-31. PubMed ID: 16886672
    [Abstract] [Full Text] [Related]

  • 15. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
    Shimizu M, Miyamoto Y, Takaku H, Matsuo M, Nakabayashi M, Masuno H, Udagawa N, DeLuca HF, Ikura T, Ito N.
    Bioorg Med Chem; 2008 Jul 15; 16(14):6949-64. PubMed ID: 18539034
    [Abstract] [Full Text] [Related]

  • 16. 2,2-Functionalized analogues of 1alpha,25-dihydroxyvitamin D3, the potent inducers of cell differentiation.
    Fujishima T, Kittaka A, Kurihara M, Saito N, Honzawa S, Kishimoto S, Sugiura T, Waku K, Takayama H.
    J Steroid Biochem Mol Biol; 2004 May 15; 89-90(1-5):89-92. PubMed ID: 15225752
    [Abstract] [Full Text] [Related]

  • 17. Regulation of the vitamin D receptor by vitamin D lactam derivatives.
    Asano L, Waku T, Abe R, Kuwabara N, Ito I, Yanagisawa J, Nagasawa K, Shimizu T.
    FEBS Lett; 2016 Sep 15; 590(18):3270-9. PubMed ID: 27500498
    [Abstract] [Full Text] [Related]

  • 18. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
    Seifert M, Rech M, Meineke V, Tilgen W, Reichrath J.
    J Steroid Biochem Mol Biol; 2004 May 15; 89-90(1-5):375-9. PubMed ID: 15225804
    [Abstract] [Full Text] [Related]

  • 19. 13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
    Plonska-Ocypa K, Sicinski RR, Plum LA, Grzywacz P, Frelek J, Clagett-Dame M, DeLuca HF.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1747-63. PubMed ID: 19167893
    [Abstract] [Full Text] [Related]

  • 20. 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells).
    Miura D, Manabe K, Gao Q, Norman AW, Ishizuka S.
    FEBS Lett; 1999 Oct 29; 460(2):297-302. PubMed ID: 10544253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.